Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-08-000009
Filing Date
2008-01-04
Accepted
2008-01-04 21:27:46
Documents
1
Period of Report
2008-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4312
  Complete submission text file 0000874015-08-000009.txt   6248
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROBERTS SHERIDAN & KOTEL 12 EAST 49TH STREET 30TH FL NEW YORK NY 10017
Business Address AVAS TECHNOLOGIES INC 4520 MAIN STREET SUITE 930 KANSAS CITY MO 64111 8169601333
JONAS JEFFREY M (Reporting) CIK: 0001042021 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 08513601